Beta-cryptoxanthin and lung cancer in Shanghai, China - An examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure

Nutrition and Cancer

Volumn 57, Issue 2, 2007, Pages 123-129

  Stram, Daniel O ^a   Yuan, Jian Min ^b   Chan, Kenneth K ^c   Gao, Yu Tang ^d   Ross, Ronald K ^a   Yu, Mimi C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BETA CRYPTOXANTHIN; COTININE;

ADULT; ARTICLE; CANCER RISK; CHINA; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DIETARY INTAKE; FRUIT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTECTION; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; STATISTICAL MODEL; TOBACCO; URINALYSIS; URINE LEVEL; VEGETABLE;

NICOTIANA TABACUM;

EID: 34447524002     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701273998     Document Type: Article

References (32)

1. Ziegler RG, Mason TJ, Stemhagen A, Hoover R, Schoenberg JB, Gridley G, Virgo PW, and Fraumeni JF, Jr.: Carotenoid intake, vegetables, and the risk of lung cancer among white men in New Jersey. Am J Epidemiol 123, 1080-1093, 1986.
2. Peto R, Doll R, Buckley JD, and Sporn MB: Can dietary β-carotene materially reduce human cancer rates? Nature 290, 201-208, 1981.
3. Subar A, Harlan L, and Mattson M: Food and nutrient intake differences between smokers and non-smokers in the US. Am J Public Health 80, 1323, 1990.
4. Osler M, Tjonneland A, Suntum M, Thomsen BL, Stripp C, Gronbaek M, and Overvad K: Does the association between smoking status and selected healthy foods depend on gender? A population-based study of 54, 417 middle-aged Danes. Eur J Clin Nutr 56, 57-63, 2002.
5. Wilson DB, Smith BN, Speizer IS, Bean MK, Mitchell KS, Uguy LS, and Fries EA: Differences in food intake and exercise by smoking status in adolescents. Prev Med 40, 872-879, 2005.
6. Park SY, Murphy SP, Wilkens LR, Yamamoto JF, Sharma S, Hankin JH, Henderson BE, and Kolonel LN: Dietary patterns using the Food Guide Pyramid groups are associated with sociodemographic and lifestyle factors: the multiethnic cohort study. J Nutr 135, 843-849, 2005.
7. Shibata A, Paganini-Hill A, Ross RK, Yu MC, and Henderson BE: Dietary β-carotene, cigarette smoking, and lung cancer in men. Cancer Causes Control 3, 207-214, 1992.
8. Stryker W, Kaplan L, Stein E, Stampfer M, Sober A, and Willett W: The relation of diet, cigarette smoking, and alcohol consumption to plasma β-carotene and α-tocopherol levels. Am J Epidemiol 127, 283-296, 1988.
9. Marshall J and Hastrup J: Mismeasurement and the resonance of strong confounders: uncorrected measurement error. Am J Epidemiol 143, 1069-1078, 1996.
10. Stram D, Huberman M, and Wu A: Is residual confounding a reasonable explanation for the apparent protective effects of β-carotene found in epidemiological studies of lung cancer in smokers? Am J Epidemiol 155, 622-628, 2002.
11. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, Cerhan JR, Colditz G, Feskanich D, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Rohan TE, Virtamo J, Willett WC, and Hunter DJ: Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 13, 40-48, 2004.
12. Yuan JM, Stram DO, Arakawa K, Lee HP, and Yu MC: Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 12, 890-898, 2003.
13. Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J, and Albanes D: Dietary carotenoids, serum β-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, β-carotene cohort study. Am J Epidemiol 156, 536-547, 2002.
14. Wright ME, Mayne ST, Swanson CA, Sinha R, and Alavanja MC: Dietary carotenoids, vegetables, and lung cancer risk in women: the Missouri women's health study (United States). Cancer Causes Control 14, 85-96, 2003.
15. Yuan JM, Ross RK, Chu XD, Gao YT, and Yu MC: Prediagnostic levels of serum β-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomarkers Prev 10, 767-773, 2001.
16. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, and Henderson BE: Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339, 943-946, 1992.
17. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, and Yu MC: Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 275, 1646-1650, 1996.
18. Benowitz NL, Kuyt F, Jacob P, III, Jones RT, and Osman AL: Cotinine disposition and effects. Clin Pharmacol Ther 34, 604-611, 1983.
19. Benowitz NL: Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18, 188-204, 1996.
20. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, and Jacobs DR: Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health 80, 1053-1056, 1990.
21. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, and Kinne S: The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 84, 1086-1093, 1994.
22. Hofer I, Nil R, Wyss F, and Battig K: The contributions of cigarette yield, consumption, inhalation and puffing behaviour to the prediction of smoke exposure. Clin Invest 70, 343-351, 1992.
23. Cope G, Nayyar P, Holder R, Brock G, and Chapple I: Near-patient test for nicotine and its metabolites in saliva to assess smoking habit. Ann Clin Biochem 37, 666-673, 2000.
24. Muranaka H, Higashi E, Itani S, and Shimizu Y: Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin, and expired carbon monoxide as biochemical tobacco smoke uptake parameters. Int Arch Occup Environ Health 60, 37-41, 1988.
25. Yang CS, and Lee MJ: Methodology of plasma retinol, tocopherol, and carotenoid assays in cancer prevention studies. J Nutr Growth Cancer 4, 19-21, 1987.
26. Stacewicz-Sapuntzakis M, Bowen PE, Kikendall JW, and Burgess M: Simultaneous determination of serum retinol and various carotenoids: their distribution in middle-aged men and women. Journal of Micronutrient Analysis 3, 27-45, 1987.
27. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971.
28. Breslow NE, and Day NE. Statistical methods in cancer research. Volume 1. The analysis of case-control studies. Lyon: IARC Scientific Publication, 1980.
29. Erlinger TP, Guallar E, Miller ER, III, Stolzenberg-Solomon R, and Appel LJ: Relationship between systemic markers of inflammation and serum β- carotene levels. Arch Intern Med 161, 1903-1908, 2001.
30. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539-545, 2001.
31. Thun MJ, Henley SJ, and Gansler T: Inflammation and cancer: an epidemiological perspective. Novartis Found Symp 256, 6-21; discussion 22-8, 49-52, 266-269, 2004.
32. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, and Le Marchand L: Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354, 333-342, 2006.